155 related articles for article (PubMed ID: 25061090)
1. Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer.
Chen KH; Shao YY; Lin ZZ; Yeh YC; Shau WY; Kuo RN; Chen HM; Lai CL; Yeh KH; Cheng AL; Lai MS
Oncologist; 2014 Sep; 19(9):951-8. PubMed ID: 25061090
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia.
Kuo HY; Lin ZZ; Kuo R; Shau WY; Lai CL; Yang YY; Shao YY; Hsu C; Cheng WF; Cheng AL; Yang JC; Lai MS
Oncologist; 2015 Sep; 20(9):1051-7. PubMed ID: 26240133
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
4. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer.
Huang CW; Sun LC; Shih YL; Tsai HL; Chen CW; Yeh YS; Ma CJ; Huang CJ; Wang JY
World J Surg Oncol; 2012 May; 10():76. PubMed ID: 22553992
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
Shau WY; Shao YY; Yeh YC; Lin ZZ; Kuo R; Hsu CH; Hsu C; Cheng AL; Lai MS
Oncologist; 2012; 17(6):856-62. PubMed ID: 22622151
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease.
Huang YC; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Chang SC; Lan YT; Wang HS; Liu CY; Yang YW; Teng HW
J Cancer Res Clin Oncol; 2011 Feb; 137(2):211-20. PubMed ID: 20387072
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
Liang YH; Shao YY; Chen HM; Cheng AL; Lai MS; Yeh KH
Anticancer Res; 2017 Dec; 37(12):7095-7104. PubMed ID: 29187501
[TBL] [Abstract][Full Text] [Related]
8. Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.
Karim S; Brennan K; Nanji S; Berry SR; Booth CM
JAMA Oncol; 2017 Oct; 3(10):1386-1392. PubMed ID: 28594974
[TBL] [Abstract][Full Text] [Related]
9. Outcome of colon cancer initially presenting as colon perforation and obstruction.
Chen TM; Huang YT; Wang GC
World J Surg Oncol; 2017 Aug; 15(1):164. PubMed ID: 28841901
[TBL] [Abstract][Full Text] [Related]
10. Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients.
Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M
BMC Cancer; 2017 Apr; 17(1):251. PubMed ID: 28390415
[TBL] [Abstract][Full Text] [Related]
11. Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Vernieri C; Galli F; Ferrari L; Marchetti P; Lonardi S; Maiello E; Iaffaioli RV; Zampino MG; Zaniboni A; De Placido S; Banzi M; Damiani A; Ferrari D; Rosati G; Labianca RF; Bidoli P; Frassineti GL; Nicolini M; Pavesi L; Tronconi MC; Buonadonna A; Ferrario S; Re GL; Adamo V; Tamburini E; Clerico M; Giordani P; Leonardi F; Barni S; Ciarlo A; Cavanna L; Gori S; Cinieri S; Faedi M; Aglietta M; Antista M; Dotti KF; Galli F; Di Bartolomeo M;
Oncologist; 2019 Mar; 24(3):385-393. PubMed ID: 30606884
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
[TBL] [Abstract][Full Text] [Related]
13. The impact of diabetes mellitus on prognosis of early breast cancer in Asia.
Chen WW; Shao YY; Shau WY; Lin ZZ; Lu YS; Chen HM; Kuo RN; Cheng AL; Lai MS
Oncologist; 2012; 17(4):485-91. PubMed ID: 22467665
[TBL] [Abstract][Full Text] [Related]
14. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
15. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Sci Rep; 2019 Aug; 9(1):11846. PubMed ID: 31413354
[TBL] [Abstract][Full Text] [Related]
17. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
Lv Z; Liang Y; Liu H; Mo D
BMC Cancer; 2021 Mar; 21(1):306. PubMed ID: 33757442
[TBL] [Abstract][Full Text] [Related]
18. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
